medline.ch Respirationstrakt Neoplasie

	Navigating tarlatamab and bispecific T-cell engager therapy in small cell lung cancer: A narrative review. Cancer Treat Res Commun Abdalla BA. PMID: 42753581 [PubMed - as supplied by publisher]
	A Multicenter Randomized Phase III Trial Comparing MET Tyrosine Kinase Inhibitors vs. Immune Checkpoint Inhibitors With or Without Chemotherapy as First-Line Treatment for Patients With Advanced Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutations: JCOG2506 (DECIDE-MET). Clin Lung Cancer Mitome N, Kunimasa K, Nomura S, Kawabata K, Masuda K, Shiraishi Y, Kenmotsu H, Ando M, Fukuda H, Okamoto I, Goto Y, Lung Cancer Study Group of the Japan Clinical Oncology Group. PMID: 42753422 [PubMed - as supplied by publisher]
	Role of CYP3A4 in the metabolism of tyrosine kinase inhibitors in non-small cell lung cancer therapy. Drug Metab Dispos Sultana S, Kamal MS, Chen H, Li W. PMID: 42753302 [PubMed - as supplied by publisher]
	Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study. JCO Precis Oncol Garma LD, Pernas S, Vicente Baz D, García Campelo R, Terrasa J, Nasarre B, Vera García R, Bermejo B, González Santiago S, Fullana B, Rodríguez-Pérez M, Fernandez Bruno M, Reboredo Rendo C, Perelló A, Jiménez D, Guerra JA, Arrazubi V, de la Cruz S, Cejalvo JM, Tebar C, Núñez Berrueco E, Hernández-Marín B, Rogado J, Olmos PM, Arbaizar LP, Villalba Oliva MA, Madrid Y, Sanz-Landaluze J, Moreno-Martín G, Morillas A, Lopez-Alonso A, Rodríguez-Patón A, Colomer R, Artés-Rodríguez A, Quintela-Fandino M. PMID: 42753220 [PubMed - indexed for MEDLINE]
	Main pulmonary artery enlargement during bevacizumab therapy in KRAS-mutant metastatic colon cancer. Cancer Chemother Pharmacol Ozbay MF, Atl, Vurgun S, Hunur M, Keven A, Sahin E, Göksu SS, Karaca M. PMID: 42752894 [PubMed - indexed for MEDLINE]
	Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study. Clin Cancer Res Ahn MJ, de Marinis F, Cho BC, Kim TM, Cheng S, Novello S, Proto C, Kim SW, Lee JS, Metro G, Sequist LV, Yang JC, Xu W, Telaranta-Keerie A, Todd A, D'Angelo G, Hartmaier R, Bonanno L. PMID: 42752799 [PubMed - as supplied by publisher]
	Molecules of lung cancer - fusion alterations in nonsmall cell lung cancer: biology and diagnostic considerations. Breathe (Sheff) Talty M, O'Reilly D, Dunne J, Naidoo J. PMID: 42751219 [PubMed]
	Individualized approach to palliative care integration for patients with metastatic non-small cell lung cancer. Front Med (Lausanne) Mitchell C, Kailar RS, Hsu ML. PMID: 42750937 [PubMed]
	Beyond tobacco: understanding the growing burden of lung adenocarcinoma in women. Oncol Rev Virata MCA, Abello RMR, Brillante EMB, Interior JS, Relacion PR, Molen RGC, Alea EPM, Mojica JCP. PMID: 42750867 [PubMed]
	ALPHA-1 antitrypsin genotype, sex, and lung cancer: Clinical and molecular characterisation. Pulmonology García-Rodríguez E, Tubío-Pérez RA, Candal-Pereira C, Villar-Aguilar L, Priegue-Carrera A, Fernández-Villar A, Ruano-Raviña A, Torres-Durán M. PMID: 42750455 [PubMed - indexed for MEDLINE]
	Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study. Ann Surg Oncol Hashimoto S, Tominaga T, Shiraishi T, Noda K, Yamashita M, Katayama H, Takamura Y, Mizoguchi S, Obata T, Taniguchi D, Doi R, Shimoyama K, Miyazaki T, Hisanaga M, Ishii M, Ono R, Nakatsukasa T, Kamohara R, Araki M, Sumida Y, Nakamura A, Nonaka T, Matsumoto K. PMID: 42749975 [PubMed - as supplied by publisher]
	mRNA-based therapeutics in lung Cancer: Mechanisms, applications, and translational challenges. J Genet Eng Biotechnol Wehbe I, Tlili A. PMID: 42749398 [PubMed]
	National trends, variation and short-term outcomes in surgery for non-small cell lung cancer in England, 2015-2023: a population-based cohort study using linked national cancer registration and hospital administrative data. BMJ Open Dixon LK, Cook S, Cook A, Thomas J, Boudour J, Chan F, Conibear J, West D, Navani N, Cromwell DA. PMID: 42749376 [PubMed - indexed for MEDLINE]
	Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination TherapyÂ With EGFR Inhibitors. Respirology Sunaga N, Hasegawa Y, Sato M. PMID: 42749289 [PubMed - as supplied by publisher]
	Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer in a Phase 2 Study. J Thorac Oncol Bauer TM, Martini JF, Besse B, Lin CC, Soo RA, Riely GJ, Wang IM, Toffalorio F, Shepard DA, Usari T, Hamilton P, Camidge DR, Kao S, Chiari R, Gadgeel S, Felip E, Shaw AT, Solomon BJ. PMID: 42749050 [PubMed - as supplied by publisher]
	Defining Early Recurrence in Resectable Non-small Cell Lung Cancer Using Post-Recurrence Survival. Lung Naeem W, Khan AA, Rabin EE, Broad S, Denson KL, Casanova T, Basu S, Alex G, Geissen N, Liptay MJ, Seder CW. PMID: 42747627 [PubMed - indexed for MEDLINE]
	Unveiling BRAF Mutations in Non-small Cell Lung Cancer: State of the Art and Future Perspectives. Lung Colombino M, Paliogiannis P, Palomba G, Pisano M, Casula M, Fois AG, Zinellu A, Palmieri G. PMID: 42747511 [PubMed - indexed for MEDLINE]
	Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis. Front Immunol Liang D, Liu Q, Liu M, Li Y. PMID: 42746176 [PubMed - indexed for MEDLINE]
	Associations of derived inflammatory, lipid, and anthropometric indices with CT-detected pulmonary nodules: a hospital-based cross-sectional study with explainable machine learning. Front Endocrinol (Lausanne) Wang M, Zhou Y, Wu B, Liu Y, Luo X, Zhang A. PMID: 42745967 [PubMed - indexed for MEDLINE]
	Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity. 3 Biotech Liu D, He B, Zhou X, Yang Y, Song M, Xu X. PMID: 42745950 [PubMed]

Artikel 1 - 20 / 163141

Seite 1 von 8158



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung